Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
IBRX
#1042
ImmunityBio, Inc. Common Stock
7.6
0
USD
+4.11%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+4.11%
Aylık Değişim
-10.80%
6 aylık değişim
+202.79%
Yıllık Değişim
+154.18%
Önceki Kapanış
7.3
0
Open
7.6
0
Bid
Ask
Low
7.6
0
High
7.6
0
Hacim
103
Piyasalar
ABD Borsası
Sağlık Hizmetleri
IBRX
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
109.34 M
397.91 M
435.84 M
673.95 M
853.44 M
1.03 B
—
Valuation ratios
Enterprise value
—
2.24 B
1.96 B
4.15 B
2.37 B
2.31 B
10.68 B
Price to earnings ratio
—
-6.83
-4.59
-4.56
-4.13
-5.21
-22.26
Price to sales ratio
—
2 533.77
7 948.02
4 284.97
121.61
16.08
155.25
Price to cash flow ratio
—
-8.62
-5.65
-7.27
-4.58
-5.97
-24.09
Price to book ratio
—
-9.77
-4.26
-4.54
-3.67
-3.64
-6.31
Enterprise value to EBITDA ratio
—
-7.08
-5.92
-9.5
-6.25
25.23
-301.82
Profitability ratios
Return on assets %
-0.61
-0.74
-1.15
-1.16
-1.08
-0.7
-0.91
Return on equity %
-0.79
1.42
0.93
1
0.85
0.7
0.63
Return on invested capital %
-406.35
-499.19
-255.38
-327.6
-630.3
-482.51
-477.16
Gross margin %
100
100
100
100
100
99.34
397.58
Operating margin %
-82.55 K
-35.36 K
-146.37 K
-58.24 K
-2 334.23
-226
-1 002.3
EBITDA margin %
-74.31 K
-33.84 K
-138.77 K
-55.26 K
-2 215.18
68.17
308.16
Net margin %
-83.23 K
-37.13 K
-173.57 K
-93.76 K
-2 804.77
-310.18
-1 506.74
Liquidity ratios
Quick ratio
—
—
—
—
3.21
5.08
16.76
Current ratio
3.06
0.91
0.28
5.05
3.36
5.1
17.19
Inventory turnover
—
—
—
—
0
0.16
0.15
Asset turnover
0
0
0
0
0.03
0.26
0.27
Solvency ratios
Debt to assets ratio
—
—
-0.04
1.75
0.85
0.73
3.4
Debt to equity ratio
—
—
0.03
-1.5
-0.67
-0.73
-2.6
Long term debt to total assets ratio
—
—
-0.18
1.66
0.74
0.65
2.99
Long term debt to total equity ratio
—
—
0.14
-1.43
-0.58
-0.65
-2.29
Per share metrics
Operating cash flow per share
—
-0.71
-0.84
-0.72
-0.56
-0.33
-0.34
EBIT per share
—
-0.85
-0.88
-0.71
-0.49
-0.28
-0.28
EBITDA per share
—
-0.81
-0.83
-0.68
-0.47
0.08
0.1
Total debt per share
—
—
-0.03
1.73
0.47
0.4
1.56
Cash per share
—
0.81
0.27
0.52
0.21
0.26
0.78
Net current asset value per share
—
0.86
0.35
0.58
0.26
0.34
1.05
Tangible book value per share
—
-0.63
-1.17
-1.19
-0.72
-0.56
-2.5
Working capital per share
—
-0.09
-0.9
0.46
0.19
0.28
0.81
Book value per share
—
-0.62
-1.12
-1.15
-0.7
-0.54
-2.43
Haberler
IBRX Stock Rises 7% on Strong Q1 2026 Preliminary Results
Why Is ImmunityBio Stock Rallying Thursday? - ImmunityBio (NASDAQ:IBRX)
ImmunityBio’nun 1Ç geliri yıllık %168 artışla 44,2 milyon dolar
ImmunityBio, FDA’nın tanıtım uyum endişelerine yanıt verdi
ImmunityBio hisseleri FDA uyum yanıtı sonrası yükseldi
ImmunityBio: No Need To Rush Into Buying Today - Why I'm Downgrading To Hold (NASDAQ:IBRX)
ImmunityBio hisseleri 100 milyon dolarlık anlaşmayla yükseldi
ImmunityBio 75 milyon dolar finansman sağladı
ImmunityBio vs. Moderna: Which Biotech Has More Upside Potential?
ImmunityBio Lead Bladder Cancer Drug Trial Clears Power Check - ImmunityBio (NASDAQ:IBRX)
ImmunityBio’nun mesane kanseri çalışması yeterli güçte bulundu
Why Is ImmunityBio (IBRX) Down 35.8% Since Last Earnings Report?